dr. miklos on the results of the zuma-2 trial in mcl
Published 4 years ago • 117 plays • Length 1:26Download video MP4
Download video MP3
Similar videos
-
1:10
dr. miklos on the safety profile of kte-x19 in mcl
-
3:54
zuma-2: outcomes of r/r mcl patients who progressed within 24 months of diagnosis
-
1:10
zuma-2 trial demonstrates similar outcomes for high- and low-risk mcl
-
1:22
zuma-2 trial demonstrates efficacy in mantle cell lymphoma
-
1:23
dr. miklos on anticipated sequencing challenges with kte-x19 in mcl
-
2:15
dr dmitry klokol: we treat the cause of the disease with cell therapy
-
3:53
dr. lim 8 | hear the protective benefits of polypodium lucotomas
-
47:37
metabolically supported chemotherapy with abdul slocum, md
-
0:55
dr. wang on the evolution of treatment in mcl
-
1:02
dr. goy on the progression of mcl treatment
-
1:59
michael wang, md, shares details from the zuma-2 trial in mantle cell lymphoma presented at ash 2019
-
1:25
dr. goy discusses single-agent ibrutinib in mcl
-
1:11
one-year follow-up of zuma-2: kte-x19 in r/r mcl
-
1:04
dr. wang on the safety profile of brexucabtagene autoleucel in relapsed/refractory mcl
-
1:41
dr. lonial on the results of the dreamm-2 trial in multiple myeloma
-
2:21
management of a patient with mcl who developed severe neurotoxicity in zuma-2
-
1:22
dr. lee on the mechanism of action of cirmtuzumab in mcl or cll
-
0:47
dr. wang on the safety profile of kte-x19 in mcl
-
1:02
andre goy, md, regarding the zuma-2 study investigating anti-cd19 car-t cell therapy mcl
-
1:14
dr. hamlin on the significance of the zuma-i trial
-
3:34
transcend study: liso-cel shows promise in r/r mcl patients
-
1:06
dr. gerson on clinical trial accrual in mcl